Save the Date for APPLIED PHARMACEUTICAL CHEMISTRY 2019!

April 5, 2019
Broad Institute
415 Main Street, Cambridge, MA 02142

 

Click Here to Download the APC 2018 Program

Plenary Speaker for APC 2018

Craig M. Crews, PhD

Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology, Professor of Chemistry, Professor of Pharmacology, Yale University

PROTAC Mediated Protein Degradation: A New Pharmaceutical Modality

   
   

 

Speakers Confirmed for APC 2018

Matthew Calabrese, Senior Principal Scientist, Structural Biology and Biophysics, Pfizer

Mechanistic Understanding of PROTAC’s as a Tool

 

Andrew Phillips, President and Chief Scientific Officer, C4 Therapeutics

Targeted Protein Degradation:  Applications to Chromatin Biology and T-Cell Biology

         

Atwood Cheung, Research Investigator, Novartis Institutes for BioMedical Research

Spinal Muscular Atrophy: Advancing Small Molecule Splicing Modulators from Phenotypic Screen to Clinic

 

Francesco G. Salituro, Vice President, Chemistry, Sage Therapeutics

Advances in Neuroactive Steroid Drug Discovery: GABA and NMDA Modulators

         
 

David DeGoey, Research Fellow, AbbVie

Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection

   

Paul Scola, Director in Drug Discovery, BMS

Discovery of a Macrocyclic Peptide Inhibitor of Programmed Death-Ligand 1 (PD-L1)

         
 

Bertrand Chenard, Executive Director Medicinal Chemistry, Sunovion Pharmaceuticals

Behavioral Phenotypic Drug Discovery

   

Jamison Tuttle, Principal Scientist, Pfizer

Identifying Brain Penetrant Janus Kinase 1 Inhibitors to Attenuate Neuroinflammation Associated with Epilepsy

         
 

Nello Mainolfi, Founder and Chief Technology Officer, Kymera Therapetics

Targeted Protein Degradation Through Rational Design

     
         

 

 

Proposed Sessions for 2018:

Session I:  PROTACs (Proteolysis Targeting Chimera)/Protein Degradation

Session II: New Approaches in CNS Disorders

Session III: Drug Discovery Beyond Rule of 5/ New Approaches to Screening Collections 

 

 

Join our LinkedIn Group

Sessions

Session I:  PROTACs (Proteolysis Targeting Chimera)/Protein Degradation

Session II: New Approaches in CNS Disorders

Session III: Drug Discovery Beyond Rule of 5/ New Approaches to Screening Collections

Registration

Click here to register for the APC 2018 conference online.

APC 2018 will take place April 5, 2018 at:

Broad Institute, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy